Sangam Life-Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 23.15%
- Ebitda 23.44%
- Net Worth -88.00%
- Total Assets -3.40%
About Sangam Life-Sciences
Sangam Life-Sciences Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 May 2017 (Seven years and eight months 9 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkatasubramanya Devarakonda, Ramana Ganakota, and Ramya Reddy serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52605TG2017PTC117354
-
Company No.
117354
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 May 2017
-
Date of AGM
25 Sep 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sangam Life-Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatasubramanya Devarakonda
|
Director | 25-May-2017 | Current |
|
Ramana Ganakota
|
Director | 25-May-2017 | Current |
|
Ramya Reddy
|
Director | 25-May-2017 | Current |
Financial Performance of Sangam Life-Sciences.
Sangam Life-Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 23.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sangam Life-Sciences?
Unlock access to Sangam Life-Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sangam Life-Sciences?
Unlock and access historical data on people associated with Sangam Life-Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sangam Life-Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sangam Life-Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.